logo

Search

Login | Create Account

oncology


Categories

Blood Breast cancer Cancer care Childhood cancers End-of-life care Endocrine GI cancer GU cancer Head and neck cancer Lung cancer Medicines Medicopolitical Melanoma Podcasts Radiation oncology Research Risk Factors Sarcoma

Other

Conferences

Specialties


Cardiology Dermatology Endocrinology Gastroenterology Haematology Neurology Oncology Respiratory Rheumatology

General


Contact Us About Us Website Disclaimer Privacy Policy Terms & Conditions

©2023 the limbic

logo

Medical oncologist recognised in Australia Day Honours

One of the country’s top paediatric oncologists has been recognised for his contribution to the specialty in the 2023 Australia Day Honours. Associate Professor Peter Downie was made a Member of the Order of Australia (AM) for “for significant service to paediatric oncology, to teaching, and to research”.The long-running head of...

Breast cancer

Study supports CDK4/6i + endocrine therapy in aggressive advanced breast cancer

First-line ribociclib plus endocrine therapy may be more effective and better tolerated than combination chemotherapy in patients with advanced breast cancer with aggressive disease features, a study has shown Results from the phase II RIGHT Choice trial presented at SABCS 2022 meeting showed that a combination of CDK4/6 inhibitor and endocrine...

Lung cancer

Screen-detected lung cancers have 80% survival rates after 20 years

Diagnosing early-stage lung cancer with low-dose CT screening drastically improves the long-term survival rate of cancer patients, a major international study has shown. Lung cancer survival rates were 80% at 20 years among 1285 participants in the International Early Lung Cancer Action Program (I-ELCAP) trial who had cancers detected by low...

GI cancer

Regorafenib improves OS in refractory advanced gastro-oesophageal cancer

Regorafenib confers an overall survival benefit over placebo when used for patients with refractory advanced gastro-oesophageal carcinoma (ACOG), an Australian-led phase 3 trial has shown. Final results from the INTEGRATE-IIa study, presented by Professor Nick Pavlakis at the at the...

Regorafenib confers an overall survival benefit over placebo when used for patients with refractory advanced gastro-oesophageal carcinoma (ACOG), an Australian-led...


GI cancer

Climate change may be driving rise in liver cancer: study

The rapid rise of liver cancer in Australia, mainly in the equatorial and tropical regions and not explained by known risk factors, has researchers questioning a link between liver cancer and climate change. The research, published in the journal Science of...

The rapid rise of liver cancer in Australia, mainly in the equatorial and tropical regions and not explained by known...


Medicine

Nurses take on sedation duties under new guidance

Nurses have been given the green light to perform procedural sedation of patients using propofol provided they work under a strict set of guidelines released by the Australian and New Zealand College of Anaesthetists. It follows a declaration by the college...

Nurses have been given the green light to perform procedural sedation of patients using propofol provided they work under a...


Cancel